HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Helicobacter Infections D016481 21 associated lipids
Granular Cell Tumor D016586 1 associated lipids
Thyroid Nodule D016606 4 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
AIDS-Related Opportunistic Infections D017088 9 associated lipids
Colitis, Ischemic D017091 3 associated lipids
Mucinoses D017520 2 associated lipids
Sarcoma, Endometrial Stromal D018203 1 associated lipids
Neoplasms, Connective and Soft Tissue D018204 1 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Skandalis SS et al. Versican but not decorin accumulation is related to malignancy in mammographically detected high density and malignant-appearing microcalcifications in non-palpable breast carcinomas. 2011 BMC Cancer pmid:21791066
Ioachim E et al. Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components. 2006 BMC Cancer pmid:16732887
El Khoury D et al. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice. 2010 BMC Cancer pmid:20573279
Rubie C et al. ELR+ CXC chemokine expression in benign and malignant colorectal conditions. 2008 BMC Cancer pmid:18578857
Ohri CM et al. Tumour necrosis factor-alpha expression in tumour islets confers a survival advantage in non-small cell lung cancer. 2010 BMC Cancer pmid:20573209
Jiang L et al. Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. 2010 BMC Cancer pmid:20569443
Nakayama T et al. Lineage analysis of early and advanced tubular adenocarcinomas of the stomach: continuous or discontinuous? 2010 BMC Cancer pmid:20565940
Seeber LM et al. Necrosis related HIF-1alpha expression predicts prognosis in patients with endometrioid endometrial carcinoma. 2010 BMC Cancer pmid:20565904
Mariani L et al. Human papillomavirus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy. 2010 BMC Cancer pmid:20525370
van Rossum AG et al. Transgenic mice with mammary gland targeted expression of human cortactin do not develop (pre-malignant) breast tumors: studies in MMTV-cortactin and MMTV-cortactin/-cyclin D1 bitransgenic mice. 2006 BMC Cancer pmid:16536875
Yan T et al. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide. 2011 BMC Cancer pmid:22185371
Meyniel JP et al. A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer. 2010 BMC Cancer pmid:20492709
Emmett MS et al. Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density. 2010 BMC Cancer pmid:20478045
Zhang D et al. Comparison of prevalence, viral load, physical status and expression of human papillomavirus-16, -18 and -58 in esophageal and cervical cancer: a case-control study. 2010 BMC Cancer pmid:21108842
Decock J et al. Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis. 2008 BMC Cancer pmid:18366705
Walker LG et al. Effects on quality of life, anti-cancer responses, breast conserving surgery and survival with neoadjuvant docetaxel: a randomised study of sequential weekly versus three-weekly docetaxel following neoadjuvant doxorubicin and cyclophosphamide in women with primary breast cancer. 2011 BMC Cancer pmid:21592370
Ohri CM et al. Chemokine receptor expression in tumour islets and stroma in non-small cell lung cancer. 2010 BMC Cancer pmid:20429924
Chodon D et al. Estrogen regulation of TRPM8 expression in breast cancer cells. 2010 BMC Cancer pmid:20482834
Sonnenberg M et al. Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breast. 2008 BMC Cancer pmid:19077243
Tuomela J et al. Fast growth associated with aberrant vasculature and hypoxia in fibroblast growth factor 8b (FGF8b) over-expressing PC-3 prostate tumour xenografts. 2010 BMC Cancer pmid:21034500
Valencia T et al. Role and expression of FRS2 and FRS3 in prostate cancer. 2011 BMC Cancer pmid:22078327
Machado CM et al. Characterization of cells recovered from the xenotransplanted NG97 human-derived glioma cell line subcultured in a long-term in vitro. 2008 BMC Cancer pmid:18840301
Gao Y et al. High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study. 2010 BMC Cancer pmid:20374665
ten Haaf A et al. Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival. 2009 BMC Cancer pmid:19706168
Roodink I et al. Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies. 2009 BMC Cancer pmid:19703316
Gericke B et al. Microheterogeneity of transthyretin in serum and ascitic fluid of ovarian cancer patients. 2005 BMC Cancer pmid:16225703
Liu J et al. Alterations of BCCIP, a BRCA2 interacting protein, in astrocytomas. 2009 BMC Cancer pmid:19653894
Aloysius MM et al. Immunohistochemical expression of mitochondrial membrane complexes (MMCs) I, III, IV and V in malignant and benign periampullary epithelium: a potential target for drug therapy of periampullary cancer? 2010 BMC Cancer pmid:20202214
Westgaard A et al. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. 2008 BMC Cancer pmid:18194510
Lips EH et al. Integrating chromosomal aberrations and gene expression profiles to dissect rectal tumorigenesis. 2008 BMC Cancer pmid:18959792
Cheng Y et al. Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. 2007 BMC Cancer pmid:17927838
Gockel I et al. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma. 2006 BMC Cancer pmid:17176471
García N et al. A molecular analysis by gene expression profiling reveals Bik/NBK overexpression in sporadic breast tumor samples of Mexican females. 2005 BMC Cancer pmid:16060964
Hungermann D et al. Adenomyoepithelial tumours and myoepithelial carcinomas of the breast--a spectrum of monophasic and biphasic tumours dominated by immature myoepithelial cells. 2005 BMC Cancer pmid:16050957
Arellano-Llamas A et al. High Smac/DIABLO expression is associated with early local recurrence of cervical cancer. 2006 BMC Cancer pmid:17067390
Wang C et al. TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients. 2010 BMC Cancer pmid:20696081
Sheahan S et al. Deficiency of G1 regulators P53, P21Cip1 and/or pRb decreases hepatocyte sensitivity to TGFbeta cell cycle arrest. 2007 BMC Cancer pmid:18021445
van Houwelingen KP et al. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study. 2005 BMC Cancer pmid:15932632
Fu J et al. In vitro anti-angiogenic properties of LGD1069, a selective retinoid X-receptor agonist through down-regulating Runx2 expression on Human endothelial cells. 2011 BMC Cancer pmid:21649908
Zhao C et al. Involvement of tumor necrosis factor-alpha in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori. 2010 BMC Cancer pmid:20699000
Boström P et al. MMP-1 expression has an independent prognostic value in breast cancer. 2011 BMC Cancer pmid:21835023
Slipicevic A et al. Cytoplasmic BRMS1 expression in malignant melanoma is associated with increased disease-free survival. 2012 BMC Cancer pmid:22356677
Fernández-Guinea O et al. Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and clinico-pathological and biological factors in invasive breast cancer. 2010 BMC Cancer pmid:20064215
Keightley MC et al. PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer. 2010 BMC Cancer pmid:20840749
Fabre-Lafay S et al. Nectin-4 is a new histological and serological tumor associated marker for breast cancer. 2007 BMC Cancer pmid:17474988
Puppin C et al. HEX expression and localization in normal mammary gland and breast carcinoma. 2006 BMC Cancer pmid:16854221
Krishnan P et al. Citrus auraptene suppresses cyclin D1 and significantly delays N-methyl nitrosourea induced mammary carcinogenesis in female Sprague-Dawley rats. 2009 BMC Cancer pmid:19640308
Webb M et al. Expression analysis of the mouse S100A7/psoriasin gene in skin inflammation and mammary tumorigenesis. 2005 BMC Cancer pmid:15717926
Wang J et al. A reproducible brain tumour model established from human glioblastoma biopsies. 2009 BMC Cancer pmid:20040089
Mesquita B et al. No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin. 2005 BMC Cancer pmid:16095531